Article Details

Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0215, a ...

Retrieved on: 2022-07-29 13:55:53

Tags for this article:

Click the tags to see associated articles and topics

Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0215, a .... View article details on hiswai:

Excerpt

STAR-0215 is an investigational monoclonal antibody inhibitor of plasma kallikrein designed to provide long-acting, effective attack prevention for ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up